S
SELLAS Life Sciences Group
SLS
1.24000
USD
0.08
(6.90%)
مغلق
حجم التداول
16,069
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
74,304,035
الأخبار
العنوان: SELLAS Life Sciences Group
القطاع: Healthcare
الصناعة: Biotechnology
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.